Tirzepatide is a dual GIP + GLP-1 agonist offering 1522% weight loss in clinical studies
Eating more fibre, lean protein, healthy fats, and water-rich fruits and vegetables can also increase GLP-1 levels naturally, supporting weight loss
Because Retatrutide simultaneously engages several tightly regulated receptor systems, experimental reliability depends heavily on peptide purity and molecular stability
A common factor in metabolic diseases like diabetes, inflammation is a key component of the body's natural immune defence mechanism to protect itself
One possible reason, investigators explained, is that these medications may affect blood flow or oxygen levels in the eye, which could also play a role in conditions such as nAMD
While medications like semaglutide focus on a single pathway that helps control appetite and blood sugar, tirzepatide activates two complementary pathways at the same time